World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
62549
World Ranking
9458
National Ranking
917

Peter M.A. Calverley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter M.A. Calverley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter M.A. Calverley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter M.A. Calverley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter M.A. Calverley is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine. Their scientific output includes 117 publications in medicine, with 87 specifically in pulmonary and respiratory medicine, highlighting a concentrated expertise in this domain.

Their research covers several interconnected subfields such as physiology, emergency medical services, cardiology and cardiovascular medicine, and surgery. Within these areas, they have explored various main topics, including chronic obstructive pulmonary disease (COPD) research, respiratory support and mechanisms, and asthma and other respiratory diseases. Additional topics of their study include respiratory and cough-related research, pediatric health and respiratory diseases, obstructive sleep apnea research, and lung cancer diagnosis and treatment.

Peter M.A. Calverley has contributed extensively to scientific literature, with notable frequent co-authors including Jadwiga A. Wedzicha, Jørgen Vestbo, James P. Allinson, Alberto Papi, and Bartolomé R. Celli. These collaborations indicate active engagement with leading figures in respiratory and pulmonary research.

The scientist has published regularly in respected journals and venues. Their most frequent publication venues are:

  • American Journal of Respiratory and Critical Care Medicine (16 publications)
  • ERJ Open Research (5 publications)
  • International Journal of COPD (3 publications)
  • European Respiratory Journal (3 publications)
  • Respiratory Research (2 publications)

Among their recent papers, some key works include:

  • Clinical significance and applications of oscillometry, 2022, European Respiratory Review
  • Machine Learning and Prediction of All-Cause Mortality in COPD, 2020, CHEST Journal
  • Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review, 2020, American Journal of Respiratory and Critical Care Medicine
  • FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease, 2020, International Journal of COPD
  • Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials, 2020, Respiratory Research

Best Publications

  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

    R A Pauwels;A S Buist;P M Calverley;C R Jenkins

  • Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

    B. R. Celli;W. MacNee;A. Agusti;Antonio R Anzueto

  • Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    John R. Hurst;Jørgen Vestbo;Jørgen Vestbo;Antonio Anzueto;Nicholas Locantore

  • An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea

    Mark B Parshall;Richard M Schwartzstein;Lewis Adams;Robert B Banzett

  • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

    Peter Calverley;Romain Pauwels;Jørgen Vestbo;Paul Jones

  • Characterisation of COPD heterogeneity in the ECLIPSE cohort

    Àlvar Agustí;Peter Ma Calverley;Bartolome R Celli;Harvey O Coxson

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

    Steven R Coughlin;Lynn Mawdsley;Julie A Mugarza;Peter M A Calverley

  • The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

    Jadwiga A. Wedzicha;Peter M. A. Calverley;Terence A. Seemungal;Gerry Hagan

  • Changes in forced expiratory volume in 1 second over time in copd

    Jørgen Vestbo;Jørgen Vestbo;Lisa D. Edwards;Paul D. Scanlon;Julie C. Yates

  • Outcomes for COPD pharmacological trials: From lung function to biomarkers

    M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe

  • Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

    Peter M A Calverley;Klaus F Rabe;Udo-Michael Goehring;Søren Kristiansen

  • Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease Results from the TORCH Study

    Bartolomé R. Celli;Nicola E. Thomas;Julie A. Anderson;Gary T. Ferguson

  • Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

    Alvar Agustí;Lisa D. Edwards;Stephen I. Rennard;William MacNee

  • Oral Corticosteroids in Patients Admitted to Hospital With Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Randomised Controlled Trial

    L Davies;R M Angus;P M A Calverley

  • Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

    S Rennard;Marc Decramer;P M A Calverley;N B Pride

  • Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

    Leonardo M Fabbri;Peter M A Calverley;José Luis Izquierdo-Alonso;Daniela S Bundschuh

  • Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

    Jadwiga A. Wedzicha;Marc Miravitlles;John R. Hurst;Peter M.A. Calverley

  • Adherence to inhaled therapy, mortality, and hospital admission in COPD

    Jørgen Vestbo;Julie A Anderson;Peter Calverley;Bartolome Celli

  • Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial

    Patrick B. Murphy;Patrick B. Murphy;Sunita Rehal;Gill Arbane;Stephen Bourke;Stephen Bourke

Frequent Co-Authors

Jørgen Vestbo
Jørgen Vestbo University of Manchester
Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Emiel F.M. Wouters
Emiel F.M. Wouters Maastricht University
Ruth Tal-Singer
Ruth Tal-Singer GlaxoSmithKline (United Kingdom)
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Antonio Anzueto
Antonio Anzueto The University of Texas Health Science Center at San Antonio
Alvar Agusti
Alvar Agusti University of Barcelona
William MacNee
William MacNee University of Edinburgh
Stephen I. Rennard
Stephen I. Rennard University of Nebraska Medical Center
David A. Lomas
David A. Lomas University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary healthcare careers is easier than ever with flexible online degree programs. If you're interested in pharmacy but want distance learning options, check out the online pharmd programs, which can prepare you for patient-focused roles as a pharmacist from the comfort of your home.

For those more inclined towards managing health data, an online mhi (Master of Health Information Management) degree can open doors to leadership positions in healthcare information systems and administration.

Looking for a fast entry into the medical field? Affordable medical billing and coding online courses cost significantly less than traditional programs, allowing you to quickly become workforce-ready in administrative healthcare roles.

Finally, consider the growing need for advanced practice nurses. Affordable online fnp programs (Family Nurse Practitioner) offer a practical, cost-effective way for registered nurses to advance their clinical skills and provide primary care across diverse settings.

Best Scientists Citing Peter M.A. Calverley

Trending Scientists

Recently Published Articles